Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590M
-
Number of holders
-
672
-
Total 13F shares, excl. options
-
180M
-
Shares change
-
-318K
-
Total reported value, excl. options
-
$16.9B
-
Value change
-
-$154M
-
Put/Call ratio
-
1.18
-
Number of buys
-
302
-
Number of sells
-
-351
-
Price
-
$93.70
Significant Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q4 2016
806 filings reported holding EW - Edwards Lifesciences Corp - Common Stock as of Q4 2016.
Edwards Lifesciences Corp - Common Stock (EW) has 672 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 180M shares
of 590M outstanding shares and own 30.57% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (19.8M shares), STATE STREET CORP (9.23M shares), SANDS CAPITAL MANAGEMENT, LLC (8.33M shares), FMR LLC (6.88M shares), WELLINGTON MANAGEMENT GROUP LLP (6.66M shares), BlackRock Institutional Trust Company, N.A. (5.68M shares), ALLIANCEBERNSTEIN L.P. (4.91M shares), AMERIPRISE FINANCIAL INC (4.89M shares), BlackRock Fund Advisors (4.35M shares), and Capital Research Global Investors (4.34M shares).
This table shows the top 672 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.